These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16273007)
1. [Therapeutic strategies in non-small-cell lung carcinoma: how to optimize patient management?]. Fournel P Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S23-30. PubMed ID: 16273007 [No Abstract] [Full Text] [Related]
2. [Lung cancer. A therapeutic challenge]. Sörenson S Lakartidningen; 1997 Apr; 94(16):1475-7. PubMed ID: 9173188 [No Abstract] [Full Text] [Related]
3. Multimodality therapy for lung cancer. Perry MC Mo Med; 1989 Nov; 86(11):733-4. PubMed ID: 2554107 [No Abstract] [Full Text] [Related]
4. [Non-small-cell bronchial cancer: medical approach]. Delaunois L; Weynants P Rev Med Suisse Romande; 1996 Feb; 116(2):79-80. PubMed ID: 8701202 [No Abstract] [Full Text] [Related]
5. Induction chemoradiotherapy for superior sulcus non-small-cell lung cancer: an answer for few. Leo F; Solli P; Veronesi G; Catalano G; De Pas T; Petrella F; Spaggiari L J Clin Oncol; 2007 May; 25(15):2146; author reply 2147. PubMed ID: 17513829 [No Abstract] [Full Text] [Related]
6. Optimizing the care of lung cancer patients: a multidisciplinary approach. Gradishar WJ; Bitran JD Hematol Oncol Clin North Am; 1990 Dec; 4(6):1023-5. PubMed ID: 1962773 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic strategies in superior sulcus tumors: a model for combined modality therapy in non-small cell lung cancer]. Girard N; Mornex F Cancer Radiother; 2007; 11(1-2):59-66. PubMed ID: 17197220 [TBL] [Abstract][Full Text] [Related]
9. Elderly lung cancer patients: what treatment strategies? Gridelli C Expert Rev Anticancer Ther; 2007 Oct; 7(10):1331-4. PubMed ID: 17944557 [No Abstract] [Full Text] [Related]
10. Lung cancer management concerns in New Zealand. Garrett J N Z Med J; 2004 Jun; 117(1196):U929. PubMed ID: 15280933 [No Abstract] [Full Text] [Related]
11. [Palliative treatment of bronchial obstruction by tumor. For whom? Why? How?]. Vergnon JM Rev Mal Respir; 1995; 12(4):331-4. PubMed ID: 7481044 [No Abstract] [Full Text] [Related]
12. Invited commentary. Falcoz PE Ann Thorac Surg; 2008 Jul; 86(1):233-4. PubMed ID: 18573429 [No Abstract] [Full Text] [Related]
13. [Treatment of unresectable stage III non-small-cell lung carcinomas]. Van Houtte P Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S24-6. PubMed ID: 17404535 [No Abstract] [Full Text] [Related]
14. [Treatment of stage III non-small lung carcinomas: is there controversy?]. Mornex F; Girard N Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S20-3. PubMed ID: 17404534 [No Abstract] [Full Text] [Related]
15. Controversies in the management of stage IIIA non-small-cell lung cancer. Santos ES; Castrellon A; Blaya M; Raez LE Expert Rev Anticancer Ther; 2008 Dec; 8(12):1913-29. PubMed ID: 19046112 [TBL] [Abstract][Full Text] [Related]
16. Invited commentary. The role of tri-modality therapy in stage III nonsmall cell lung cancer (NSCLC) is highly controversial. Kodama K Ann Thorac Surg; 2008 Sep; 86(3):910-1. PubMed ID: 18721581 [No Abstract] [Full Text] [Related]
20. [Association of molecular biology of lung cancers and their metastasis and prognosis]. Mao YS; Gao YN; He J Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):632-4. PubMed ID: 17236563 [No Abstract] [Full Text] [Related] [Next] [New Search]